Skip to main content
logo
/
Axogen, Inc. (AXGN)
NASDAQ: AXGN · Real-Time Price · USD
13.22
-0.25 (-1.82%)
At close: Jul 24, 2025, 4:00 PM
13.21
0.00 (-0.04%)
After-hours: Jul 24, 2025, 4:10 PM EDT

Axogen Revenue

Axogen had revenue of $48.56M in the quarter ending March 31, 2025, with 17.36% growth. This brings the company's revenue in the last twelve months to $194.52M, up 18.81% year-over-year. In the year 2024, Axogen had annual revenue of $187.34M with 17.81% growth.

Revenue (ttm)
$194.52M
Revenue Growth
+18.81%
P/S Ratio
3.10
Revenue / Employee
$430,354
Employees
452
Market Cap
602.55M

Revenue Chart

Created with Highcharts 11.4.8Axogen Revenue - Annual112.3M​112.3M127.4M​127.4M138.6M​138.6M159.0M​159.0M187.3M​187.3M20202021202220232024-50M100M150M200M

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024187.34M28.33M17.81%
Dec 31, 2023159.01M20.43M14.74%
Dec 31, 2022138.58M11.23M8.81%
Dec 31, 2021127.36M15.06M13.41%
Dec 31, 2020112.30M5.59M5.24%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group410.06B
Johnson & Johnson90.63B
Merck & Co.63.92B
AbbVie57.37B
Novartis AG55.19B
AstraZeneca54.98B
Eli Lilly and Company49.00B
Novo Nordisk43.92B
Revenue Rankings

AXGN News

More News